White Ash Pollen Solution
Product Images NDC 22840-1428

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for White Ash Pollen (NDC 22840-1428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Greer Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3481-2_sweetgum_10-wv (3481 2 Sweetgum 10 Wv)

Label for Acacia Pollen allergenic extract solution, proprietary name SWEETGUM POLLEN, with active ingredient Liquidambar styraciflua. The vial contains 10 mL with a concentration of 1:10 W/V and preservative phenol 0.4%. The potency is 20,000 PNU/mL. The label includes storage instructions at 2-8°C and mentions no U.S. standard of potency. Manufactured by Greer Laboratories, Inc., Lenoir, NC.*

FDA Label Image

5453-4_red Oak_20-wv (5453 4 Red Oak 20 Wv)

Label of an allergenic extract vial for Red Oak Pollen (Quercus rubra) by Greer Laboratories, Inc. The vial size is 50 mL with a concentration of 1:20 W/V. Contains 0.2% phenol preservative and 50% glycerin. The label includes item number, GTIN, serial number, lot code, expiration date (01 Jan 2025), and storage instructions (2-8°C).*

FDA Label Image

Figure 1

Two-part instructional diagram showing a Greer Laboratories occlusion test device. The left image presents the device flat with measurement scales and labeled circles for allergen application. The right image demonstrates device placement on skin with a drop dispensed from the device onto the surface. The device is used for intradermal, percutaneous, or subcutaneous allergenic testing.*

FDA Label Image

Figure 2

A flowchart illustrating an algorithm for skin testing in patients suspected of allergic reactions. It guides steps based on risk assessment and results of percutaneous skin testing, with specified dilutions of test extract at various stages. The diagram includes a note advising the use of positive and negative controls in skin test applications.*

FDA Label Image

Length And Midpoint Orthogonal Width

An instructional diagram illustrating a skin wheal and flare reaction. The image shows an arm with a raised, reddish wheal area and a surrounding red flare (erythema). Accompanying text explains the wheal as a smooth, slightly elevated area paler than surrounding skin and the flare as the red outermost zone of the wheal reaction.*

FDA Label Image

Measure The Flare

Illustration showing an arm with a marked red skin reaction area. The image indicates measurements of the reaction size, labeled as 36 mm in length and 26 mm in width at midpoint orthogonal, likely demonstrating a skin test response.*

FDA Label Image

Measuring The Wheal

An illustration showing a close-up view of skin with marked dimensions for a reaction site, indicating a length of 16 mm and an orthogonal width midpoint of 10 mm. The skin area around the site appears red, suggesting inflammation or an allergic reaction measurement typically associated with allergenic testing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.